Bremelanotide PT 141 in Stock Hot Selling 99% Purity CAS 189691-06-3 Bremelanotide PT 141 Safe Delivery Manufacturer Supply Raw Material Good Quality Best Price

Bremelanotide is an oligopeptide. |Bremelanotide is a 7-amino acid peptide used to treat hypoactive sexual desire disorder in premenopausal women. Bremelanotide does not interact with alcohol. The mechanism by which bremelanotide's action on the receptor translates into clinical effect is unknown. Bremelanotide was first described in the literature in 2003 under the trial code PT-141. Since then, it has been studied for the treatment of sexual dysfunction in both men and women, but is now only indicated for use in women. Other drugs used to treat sexual dysfunction in women include [flibanserin], [estrogens], [ospemifene], and [prasterone]. Bremelanotide was approved by the FDA on June 21, 2019. |Bremelanotide is a parenterally administered melanocortin receptor agonist used to treat hypoactive sexual desire disorder in women. Bremelanotide has been reported to cause mild elevations in serum enzymes during treatment and has been associated with clinically apparent acute liver injury in rare cases.